Doubt delayed the truth: What the tobacco industry taught us about science

 

BY the time the world fully accepted that smoking causes lung cancer and other serious diseases, millions of lives had already been affected. This delay did not occur because science was weak, but because it was challenged, questioned, and overshadowed.

As we mark World Health Day 2026, led by the World Health Organization under the theme “Together for health. Stand with science,” the history of tobacco serves as a reminder of why evidence-based science is essential in protecting public health.

Early warning signs were there

In the early 20th century, lung cancer was rare. However, by the 1920s and 1930s, doctors began to observe a sharp rise in cases. At the time, multiple causes were proposed, including industrial pollution, road tar, and past infections. Smoking was only one of several suspected factors.

By the 1940s, clearer patterns began to emerge. Doctors observed damage in the lungs of smokers, including ciliostasis—a condition in which the lungs lose their ability to clear harmful particles effectively.

Early cancerous changes were also increasingly detected in smokers during autopsies. These findings raised concern, but were still not sufficient to convince the public. Smoking was a social norm at the time, with doctors even appearing in cigarette advertisements promoting certain brands as “healthier” or gentler on the throat.

Convergence of stronger evidence

(Image: Respiratory Therapy)

The 1950s marked a turning point. Large-scale studies from the United Kingdom and the United States showed a strong and consistent link between smoking and lung cancer. These findings were replicated across different populations and research methods.

One of the most influential studies, the British Doctors Study, followed thousands of physicians over time. It demonstrated that the more a person smoked, the higher their risk of dying from lung cancer and other diseases.

Smoking was shown to reduce life expectancy by up to 10 years. Many doctors, including lead researcher Richard Doll, quit smoking after observing the results.

At the same time, laboratory research strengthened the evidence base. Tobacco tar was shown to induce tumours in animals, and carcinogenic chemicals were identified in cigarette smoke.

Converging lines of evidence—clinical observation, population studies, and experimental research—were now pointing in the same direction.

From association to causation

By the mid-1960s, scientists applied the Bradford Hill criteria, a framework used to assess whether an observed relationship is causal. Smoking met these criteria: the association was strong and consistent, risk increased with exposure, and smoking preceded disease onset.

In 1964, a landmark Surgeon General’s report concluded that smoking causes lung cancer. This should have settled the issue. The scientific evidence was already robust, consistent, and comprehensive.

Despite the strength of the evidence, public acceptance was delayed by deliberate efforts to manufacture doubt.

The tobacco industry argued that the evidence was “not conclusive” and suggested alternative causes such as air pollution or genetics. The repeated emphasis that “more research is needed” created the impression of ongoing uncertainty.

The industry also challenged study methods, highlighted potential biases, and funded research that focused on ambiguity rather than clarity. By isolating individual findings and questioning them separately, they obscured the broader consensus that smoking was the primary cause.

Shifting the message: From denial to reassurance

As scientific evidence became overwhelming, outright denial became less effective. The strategy shifted from rejecting harm to promoting “safer” alternatives, such as filtered, low-tar, or “light” cigarettes.

In more recent years, similar messaging has been applied to vaping and e-cigarettes, often promoted as reduced-risk products.

(Image: 2Firsts)

While marketed as harm-reducing, later studies showed that smokers often compensated by inhaling more deeply or smoking more frequently, resulting in similar levels of exposure. The risk was not eliminated but reframed in more reassuring language.

This progression—from denial, to doubt, to alternative reassurance—illustrates how messaging can evolve to preserve confidence despite scientific consensus.

The tobacco case demonstrates that science does not rely on a single study. It develops cumulatively through multiple, independent lines of evidence that reinforce one another. Clinical observations, epidemiological studies, laboratory experiments, and biological mechanisms collectively established the harms of smoking.

When these lines converge, conclusions become highly reliable. However, when isolated findings are emphasised or doubt is amplified, public understanding can be delayed, with serious consequences for public health.

Standing with science requires understanding this process. Scientific certainty strengthens over time as evidence accumulates, but it can be undermined when uncertainty is strategically amplified.

Standing together for health

Today, the dangers of smoking are widely accepted, but the lessons remain relevant. In an era of rapid information flow and misinformation, reliance on credible, evidence-based science is more important than ever.

The theme “Together for health. Stand with science” is more than a slogan. It is a reminder that public health depends on trust in evidence, support for scientific inquiry, and informed decision-making.

The history of tobacco offers a simple but powerful lesson: the evidence was always there, but its acceptance was delayed—and that delay came at a cost.

Standing with science today helps ensure that similar delays do not occur in the future, protecting generations to come. 

Dr Chow Sze Loon is a Public Health Physician & Occupational Health Doctor at Penang Adventist Hospital.

The views expressed are solely of the author and do not necessarily reflect those of  MMKtT.

- Focus Malaysia